236 related articles for article (PubMed ID: 12768671)
1. [Effects of intranasal budesonide on the infiltration and activation of eosinophils in nasal polyps].
Zhang L; Han D; Zhang Y; Zhou B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):129-32. PubMed ID: 12768671
[TBL] [Abstract][Full Text] [Related]
2. Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient.
Ogata Y; Okinaka Y; Takahashi M
Rhinology; 1999 Mar; 37(1):16-20. PubMed ID: 10229976
[TBL] [Abstract][Full Text] [Related]
3. [The infiltration and activation stage of eosinophils in nasal polyps].
Zhang L; Han D; Zhang Y; Zhou B
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Nov; 15(11):486-8. PubMed ID: 12541824
[TBL] [Abstract][Full Text] [Related]
4. Clinical factors influencing the eosinophil infiltration of nasal polyps.
Jankowski R; Bouchoua F; Coffinet L; Vignaud JM
Rhinology; 2002 Dec; 40(4):173-8. PubMed ID: 12526243
[TBL] [Abstract][Full Text] [Related]
5. Nasal polyp inflammation. Effect of topical nasal steroid.
Kanai N; Denburg J; Jordana M; Dolovich J
Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids.
Pujols L; Alobid I; Benítez P; Martínez-Antón A; Roca-Ferrer J; Fokkens WJ; Mullol J; Picado C
Allergy; 2008 Oct; 63(10):1377-86. PubMed ID: 18671773
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil activation in the tissue: synthetic steroid, budesonide, effectively inhibits the survival of eosinophils isolated from peripheral blood but not nasal polyp tissues.
Nonaka R; Nonaka M; Takanashi S; Jordana M; Dolovich J
J Clin Lab Immunol; 1999; 51(1):39-53. PubMed ID: 11424740
[TBL] [Abstract][Full Text] [Related]
8. Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps.
Hyo S; Kawata R; Kadoyama K; Eguchi N; Kubota T; Takenaka H; Urade Y
Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):693-700. PubMed ID: 17638783
[TBL] [Abstract][Full Text] [Related]
9. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone.
Hamilos DL; Leung DY; Muro S; Kahn AM; Hamilos SS; Thawley SE; Hamid QA
J Allergy Clin Immunol; 2001 Jul; 108(1):59-68. PubMed ID: 11447383
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids.
Kim YK; Uno M; Hamilos DL; Beck L; Bochner B; Schleimer R; Denburg JA
Am J Respir Cell Mol Biol; 1999 Mar; 20(3):388-97. PubMed ID: 10030836
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
[TBL] [Abstract][Full Text] [Related]
12. [A new system for the classification of ethmoid polyposis. Effect of combined local and systemic steroid therapy].
Rasp G; Kramer MF; Ostertag P; Kastenbauer E
Laryngorhinootologie; 2000 May; 79(5):266-72. PubMed ID: 10911602
[TBL] [Abstract][Full Text] [Related]
13. Topical budesonide treatment reduces endothelial expression of intercellular adhesion molecules (vascular cell adhesion molecule-1 and P-selectin) and eosinophil infiltration in nasal polyps.
Tingsgaard PK; Bock T; Larsen PL; Tos M
Acta Otolaryngol; 1999; 119(3):362-8. PubMed ID: 10380744
[TBL] [Abstract][Full Text] [Related]
14. The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps.
Beata RN; Wojciech F; Stanisław S; Ryszard M
Auris Nasus Larynx; 2005 Sep; 32(3):225-9. PubMed ID: 16024204
[TBL] [Abstract][Full Text] [Related]
15. Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps.
Ebbens FA; Maldonado M; de Groot EJ; Alobid I; van Drunen CM; Picado C; Fokkens WJ; Mullol J
Allergy; 2009 Jan; 64(1):96-103. PubMed ID: 19132974
[TBL] [Abstract][Full Text] [Related]
16. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment.
Valera FC; Queiroz R; Scrideli C; Tone LG; Anselmo-Lima WT
Clin Exp Allergy; 2009 Jan; 39(1):81-8. PubMed ID: 19068102
[TBL] [Abstract][Full Text] [Related]
17. Videoendoscopic analysis of nasal steroid distribution.
Weber R; Keerl R; Radziwill R; Schick B; Jaspersen D; Dshambazov K; Mlynski G; Draf W
Rhinology; 1999 Jun; 37(2):69-73. PubMed ID: 10416252
[TBL] [Abstract][Full Text] [Related]
18. Nasal inflammation induced by a common cold: comparison between controls and patients with nasal polyposis under topical steroid therapy.
Dassonville C; Bonfils P; Momas I; Seta N
Acta Otorhinolaryngol Ital; 2007 Apr; 27(2):78-82. PubMed ID: 17608135
[TBL] [Abstract][Full Text] [Related]
19. Practical issues relating to intranasal steroid therapy.
Tan LK
Singapore Med J; 2002 Aug; 43(8):412-4. PubMed ID: 12507027
[No Abstract] [Full Text] [Related]
20. Topical steroids do not downregulate expression of growth-related oncogene-alpha in nasal polyps.
Cardell LO; Bogefors J; Bjartell A; Adner M; Uddman R; Egesten A
Acta Otolaryngol; 2006 Apr; 126(4):375-80. PubMed ID: 16608789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
